Ovarian Granulosa Cell Tumor
3 clinical trials · Condition
◉ Watch Ovarian Granulosa Cell Tumor
| Record | Firm | Date |
|---|---|---|
| Nirogacestat in Ovarian Granulosa Cell Tumors (NCT05348356) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2022-08-30 |
| Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors (NCT01042522) | GOG Foundation | 2010-02-08 |
| Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary (NCT00748657) | National Cancer Institute (NCI) | 2008-09-22 |
Track Ovarian Granulosa Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.